RadaHaim
PrivateLast Round
Accelerator
May 1, 2026
Est. Valuation
$4.76M
Total Funding Raised
$320,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RadaHaim operates in Healthcare & Life Sciences and is based in Seongnam-si. Its latest recorded funding round was an Accelerator round in May 2026.
RadaHaim is a biotechnology company that develops high-throughput organoid assay systems and automated mass production platforms for drug discovery and preclinical testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RadaHaim Comparables
Compare RadaHaim with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Polyphron | 75% |
For institutional investors. Book with your work email.
RadaHaim Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 1, 2026 | ||||
| Seed | Apr 28, 2023 |
For institutional investors. Book with your work email.
RadaHaim Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Securities | Seed |
| Coolidge Corner Investment | Seed |
| 3DEXPERIENCE Lab | Accelerator |
| Tech Incubator Program for Startups | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2026
Received funding from 3DEXPERIENCE Lab.
- Apr 28, 2023
$320K round led by Coolidge Corner Investment
For institutional investors. Book with your work email.
RadaHaim Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RadaHaim's valuation, stock price, and market status.
Is RadaHaim a public or private company?
RadaHaim is a private company.
What is the current stock price of RadaHaim?
RadaHaim is a private company, so its shares have no public market price. Caplight tracks RadaHaim's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RadaHaim worth (valuation)?
RadaHaim's valuation is estimated at $4.8M based on funding round data.
Can I buy RadaHaim stock?
RadaHaim shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RadaHaim's last funding round?
RadaHaim's most recent funding round was Accelerator on May 1, 2026.
Who are the main investors in RadaHaim?
Key investors in RadaHaim include Coolidge Corner Investment.
Will RadaHaim IPO soon?
No public IPO plans have been announced for RadaHaim.
How can I track RadaHaim secondary market activity?
Caplight tracks bids, offers, and trades in RadaHaim's shares on secondary markets.